Nutraceutical Excipients Market By Excipients Type (Binders, Stabilizers, Sweeteners, Coatings and Film Formers); By Application (Dietary Supplements, Functional Foods, Pharmaceuticals, Beverages); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Nutraceutical Excipients Market Size and Formulation Demand Outlook – (Updated On: 31-Aug-2026)

The Global Nutraceutical Excipients Market was valued at USD 7.78 billion in 2025 and is projected to reach USD 14.77 billion by 2032, expanding at a CAGR of 9.6% during 2026–2032, according to Strategic Market Research.

 

Nutraceutical excipients are non-active formulation materials used to give dietary supplements and functional nutrition products the processing, stability, texture and sensory characteristics needed for reliable manufacturing and consumer use. Depending on the dosage form, they can support powder flow, tablet strength, disintegration, moisture management, suspension, taste masking, sweetness balance and protective coating.

 

Demand is increasing as supplement brands move beyond basic tablets and capsules toward gummies, chewables, powders, stick packs, effervescents and functional drinks. These formats expose more of the active ingredient to the consumer and place greater pressure on texture, flavor, flow, stability and manufacturability, increasing the commercial value of multifunctional excipient systems and formulation support.

 

The underlying demand base remains broad. The Council for Responsible Nutrition’s 2024 U.S. consumer survey found that 75% of adults used dietary supplements, while specialty-product use continued to broaden across categories such as magnesium, prebiotics and ashwagandha. FDA also identifies tablets, capsules, softgels, powders, bars, gummies and liquids among common supplement forms, reinforcing the need for excipient technologies that can work across increasingly diverse delivery formats. [1][2]

 

Key Nutraceutical Excipients Market Report Takeaways

By Excipients Type:

• Binders — 31.0% share, USD 2.412 billion in 2025 and 9.0% CAGR; the largest category because compressed nutraceutical formats need dependable flow, cohesion and tablet strength, particularly as active loading rises.

• Stabilizers — 27.0% share, USD 2.101 billion and 9.5% CAGR; demand is supported by probiotics, botanical extracts, minerals, emulsions, proteins and other formulations sensitive to separation, moisture or texture change.

• Sweeteners — 22.0% share, USD 1.712 billion and 9.8% CAGR; growth is linked to gummies, chewables, powders and beverage-style supplements where taste directly affects repeat use.

• Coatings and Film Formers — 20.0% share, USD 1.556 billion and 10.5% CAGR; the fastest-growing type as manufacturers seek moisture protection, taste and odor masking, easier swallowing and reformulation-ready coating systems.

 

By Application:

• Dietary Supplements — 46.0% share, USD 3.579 billion and 9.7% CAGR; the leading application because tablets, capsules, powders, chewables and effervescents typically combine several excipient functions.

• Functional Foods — 23.0% share, USD 1.789 billion and 10.2% CAGR; the fastest-growing application as functional ingredients move into convenient foods that require texture, stabilization and sensory management.

• Pharmaceuticals (consumer-health overlap only) — 19.0% share, USD 1.478 billion and 8.8% CAGR; this category captures pharma-grade excipient systems used in nutraceutical and consumer-health formulations, not conventional prescription-drug excipient sales.

• Beverages — 12.0% share, USD 0.934 billion and 9.9% CAGR; growth reflects rising use of proteins, minerals, botanicals, electrolytes, fibers and vitamins in ready-to-drink and ready-to-mix products.

 

By Geography:

• North America — 34.0% share, USD 2.645 billion and 9.1% CAGR; the largest regional market, supported by high supplement use, frequent reformulation and an established contract-manufacturing base.

• Asia Pacific — 29.0% share, USD 2.256 billion and 10.8% CAGR; the fastest-growing region as local supplement manufacturing, convenient dosage formats and regional formulation capabilities expand.

• Europe — 27.0% share, USD 2.101 billion and 8.7% CAGR; a mature market where coating, color, label and formulation changes sustain recurring demand for qualified excipient systems.

• Latin America — 6.0% share, USD 0.467 billion and 9.8% CAGR; functional foods and drinks are widening demand for stabilizers, sweeteners and taste-management systems.

• Middle East and Africa — 4.0% share, USD 0.311 billion and 10.1% CAGR; growth comes from a smaller base as supplement availability and standardized herbal and nutritional formats increase.

 

Dosage-Format Innovation Is Raising Excipient Value per Product

The strategic growth mechanism in this market is not simply “more supplements.” It is the migration toward harder-to-formulate products. A conventional capsule can isolate bitter or metallic ingredients from the palate, while gummies, powders, shots and chewables expose those ingredients directly. Kerry’s 2026 supplement taste analysis highlights bitterness, metallic notes and other off-flavors from botanicals, minerals and amino acids as recurring challenges across gummies, powders, shots and chews. This pushes formulation spend toward masking systems, sweetness optimization and mouthfeel control rather than sweetness alone. [3]

Multifunctional excipients are also gaining importance because they can reduce the number of separate formulation steps. JRS Pharma describes PROSOLV NX as a direct-compression nutraceutical composite combining binder, glidant, disintegrant and lubricant functions. Innophos positions its co-processed A-Tab MD and Nutra-Tab systems around compressibility, smaller tablets and simplified formulation. These propositions are commercially relevant where manufacturers want higher active loading, faster scale-up and fewer processing variables. [4][5]

Film coatings are moving from a cosmetic finish toward a functional platform. Colorcon’s current nutraceutical range includes moisture-protection, high-performance, easy-swallow, label-friendly and titanium-dioxide-free Nutrafinish systems plus Nutrateric delayed-release coating. Ashland similarly markets Aquarius Nutra TF as a titanium-dioxide-free coating for nutraceutical solid dosage forms and Aquarius Protect for moisture, taste and odor barriers. The competitive opportunity is therefore shifting toward coatings that solve stability, sensory and reformulation requirements at the same time. [6][7]

 

Excipient-Type Dynamics Favor Multifunctionality and Reformulation

Binders held the largest position with a 31.0% share and USD 2.412 billion in 2025 and are projected to grow at a 9.0% CAGR. Higher concentrations of minerals, botanicals and specialty actives can weaken flow and compactability, making reliable compression more difficult. JRS Pharma’s PROSOLV NX is designed specifically for direct-compression nutraceutical applications, while DFE Pharma’s Pharmacel microcrystalline cellulose grades are positioned for direct compression, dry granulation and high-dose formulations. For nutraceutical manufacturers, the value proposition is reduced tableting risk and the ability to maintain tablet strength without excessive size or processing complexity. [4][8]

Stabilizers accounted for 27.0% of revenue, equivalent to USD 2.101 billion in 2025, and are forecast to expand at a 9.5% CAGR. Demand increases when proteins, minerals, fibers, botanicals and live-microbial ingredients create settling, separation, viscosity or moisture-management problems. Hydrocolloids and cellulose-based systems can support suspension and texture while helping functional foods and beverages tolerate higher ingredient loads. This makes stabilizer selection increasingly important at the interface between nutritional efficacy and acceptable consumer experience.

Sweeteners represented 22.0% of the market and USD 1.712 billion in 2025 and are projected to grow at a 9.8% CAGR. The category benefits from the shift toward formats in which active ingredients are tasted rather than swallowed inside a capsule. Kerry’s recent work on supplement taste emphasizes targeted masking of bitterness, astringency and metallic notes rather than simply increasing flavor load. As brands reduce sugar or formulate with botanicals, minerals and protein, sweetener systems increasingly work alongside masking and modulation technologies. [3]

Coatings and film formers generated USD 1.556 billion and 20.0% of 2025 revenue and have the highest excipient-type CAGR at 10.5%. Growth is being reinforced by moisture-sensitive actives, swallowing preferences, clean-label requirements and regulatory-driven color reformulation. Colorcon offers nutraceutical-specific titanium-dioxide-free and label-friendly coating systems, while Ashland’s Aquarius Nutra TF and Protect platforms target titanium-dioxide replacement and barrier performance. This is one of the clearest areas where regulatory change, product appearance and manufacturing economics converge. [6][7]

 

Application Growth Is Moving Beyond Conventional Tablets

Dietary supplements generated USD 3.579 billion in 2025, representing 46.0% of the market, and are forecast to grow at a 9.7% CAGR. The segment remains the largest because tablets, capsules, powders, chewables and effervescents can require binders, diluents, disintegrants, lubricants, sweeteners, stabilizers and coatings around the active ingredient. Innophos markets calcium-phosphate and co-processed excipients across tablets, capsules, gummies and nutritional beverages, while Fuji Chemical offers F-MELT F1 specifically for dietary supplement applications. These systems target compactability, disintegration and consumer-friendly dosage design. [5][9]

Functional foods accounted for 23.0% and USD 1.789 billion in 2025 and have the fastest application CAGR at 10.2%. Fortification is expanding into snacks, bars, dairy alternatives, bakery products and other everyday formats, where the challenge is to incorporate proteins, fibers, minerals, botanicals or other functional ingredients without unacceptable grittiness, separation, dryness or flavor impact. The commercial opportunity therefore extends beyond “food additives” toward formulation systems that preserve a familiar eating experience while carrying a functional claim or nutrient load.

Pharmaceuticals, interpreted in this report only as the consumer-health overlap, represented 19.0% of revenue and USD 1.478 billion in 2025 and are projected to expand at an 8.8% CAGR. This category captures pharma-grade excipients used in nutraceutical products manufactured with oral-solid-dose technologies; it excludes excipient sales into conventional prescription medicines. BASF’s Kollidon family illustrates the technology crossover through povidone, copovidone and crospovidone functions for binding, disintegration and dissolution, while DFE Pharma’s MCC grades provide direct-compression and filler-binder functionality. The relevant market opportunity is the transfer of established oral-dose formulation technology into high-quality consumer-health products. [10][8]

Beverages held a 12.0% share and USD 0.934 billion in 2025 and are forecast to grow at a 9.9% CAGR. Protein, electrolytes, vitamins, fiber and botanical ingredients can introduce haze, sedimentation, bitterness and undesirable mouthfeel, increasing demand for stabilization and taste-management systems. Kerry’s 2025 research across 1,200 consumers in six Latin American countries found 80% familiarity with functional foods and beverages, demonstrating that functional positioning is becoming mainstream across a large emerging-market consumer base. [11]

 

Regulatory Reformulation Is Creating New Excipient Opportunities

Regulation increasingly affects excipient selection because nutraceutical products sit within food and dietary-supplement frameworks rather than conventional drug approval pathways. In the United States, FDA regulates dietary supplements as food, and on August 10, 2026 proposed a rule to increase oversight and transparency for substances claimed to be Generally Recognized as Safe (GRAS). FDA has also revoked authorization for FD&C Red No. 3 in foods, including dietary supplements, with a January 15, 2027 reformulation deadline. The agency’s August 2026 tracker additionally documents manufacturer commitments to remove petroleum-based food dyes, accelerating interest in alternative colors and coating systems. In Europe, Regulation (EU) 2022/63 removed authorization for titanium dioxide (E171) as a food additive, sustaining demand for titanium-dioxide-free coating approaches. In India, FSSAI continues to maintain a dedicated framework for health supplements, nutraceuticals, functional foods, probiotics and related products. These rules do not automatically increase total supplement consumption, but they can increase formulation work, documentation requirements and demand for excipients that provide equivalent color, opacity, protection, stability or processing performance under changing ingredient constraints. [2][12][13][14][15] [19]

 

Regional Growth Reflects Different Formulation and Consumption Priorities

North America held the largest regional position with a 34.0% share and USD 2.645 billion in 2025 and is forecast to grow at a 9.1% CAGR. The region combines high supplement penetration with frequent product launches and reformulation. CRN reported that 75% of U.S. adults used dietary supplements in 2024, while Colorcon maintains a broad nutraceutical-specific coating portfolio covering moisture protection, easy swallow, label-friendly, delayed-release and titanium-dioxide-free systems. This combination of a large consumer base and active formulation change supports recurring demand rather than one-time excipient purchases. [1][6]

Asia Pacific represented 29.0% of the market and USD 2.256 billion in 2025 and has the highest regional CAGR at 10.8%. Growth is supported by local supplement manufacturing, traditional and botanical ingredient use, and rising adoption of convenient formats. Fuji Chemical’s F-MELT portfolio includes a grade specifically designed for dietary supplements, while its Neusilin and Fujicalin platforms support flow, compression and oral-dose formulation. Regional suppliers with technical and manufacturing presence can compete effectively where customers value shorter qualification cycles and application support close to production sites. [9]

Europe generated USD 2.101 billion in 2025, equal to 27.0% of global revenue, and is projected to grow at an 8.7% CAGR. The market is comparatively mature, but ingredient and coating reformulation creates recurring technical demand. The EU restriction on titanium dioxide as a food additive has encouraged alternative white, pigmented and opacity solutions for products regulated as foods, which is visible in the nutraceutical coating portfolios now promoted by Colorcon and Ashland. [14][6][7]

Latin America accounted for USD 0.467 billion and 6.0% of 2025 revenue and has a 9.8% CAGR. Functional foods and beverages are an increasingly important excipient demand channel. Kerry’s 2025 survey of 1,200 consumers across Mexico, the Dominican Republic, Colombia, Guatemala, Brazil and Peru found 80% familiarity with functional foods and beverages. That creates a direct formulation opportunity for stabilizers, sweeteners, taste-masking systems and texture solutions when nutritional ingredients are moved into mainstream food and drink formats. [11]

The Middle East and Africa represented USD 0.311 billion and 4.0% of the market in 2025 and are forecast to grow at a 10.1% CAGR. Expansion begins from a smaller manufacturing and consumption base, with wider access to powders, gummies, nutritional beverages and standardized herbal products increasing formulation needs. Taste masking and stabilization are particularly relevant where traditional botanical ingredients are converted into repeatable commercial dosage forms rather than sold primarily as raw or minimally processed products.

 

Competitive Advantage Is Shifting from Commodity Supply to Formulation Platforms

Competition remains fragmented across global excipient manufacturers, specialist coating and formulation companies, food-ingredient groups and regional suppliers. The strategic dividing line is increasingly capability rather than product count: suppliers able to combine direct-compression systems, coatings, stabilization, sensory support, documentation and application expertise can capture more value from a single formulation. Switching is also constrained by the need to revalidate processing, stability, sensory performance and product quality, which rewards suppliers that can deliver consistency and technical support across manufacturing sites.

Roquette has materially broadened its position following completion of the IFF Pharma Solutions acquisition on May 1, 2025. Its current dietary-supplement portfolio includes Ac-Di-Sol and Accelerate disintegrants, Avicel and Endurance cellulose binders, Aquateric N100 delayed-release coating, METHOCEL functional cellulose systems, Gelcarin stabilizing technology, SeaGel vegan softgel technology and VERDIGEL SC. The acquisition strengthens Roquette’s ability to compete across solid-dose formulation, coating, stabilization and plant-based delivery rather than through a single excipient family. [16][17]

Colorcon is differentiated by nutraceutical-specific coating and finished-dose protection. Nutrafinish spans moisture-protection, high-performance, easy-swallow, label-friendly and titanium-dioxide-free systems, while Nutrateric provides delayed-release functionality. This portfolio is strategically positioned for brands facing simultaneous requirements around stability, swallowability, appearance and reformulation. [6]

JRS Pharma competes in multifunctional direct compression through PROSOLV NX, which combines binder, glidant, disintegrant and lubricant functions in a nutraceutical-focused composite. Innophos participates through A-Tab MD, Nutra-Tab and broader calcium-phosphate/co-processed excipient systems for tablets, capsules, gummies and nutritional beverages. Fuji Chemical adds specialty functionality through F-MELT, Fujicalin and Neusilin, including the F-MELT F1 grade designed for dietary supplements. [4][5][9]

Ashland competes in nutraceutical film coatings through Aquarius Nutra TF, Organic and Protect systems, including titanium-dioxide-free and barrier formulations. DFE Pharma and BASF are best viewed as pharma-origin crossover suppliers: Pharmacel MCC and Kollidon technologies provide proven binding, compression and disintegration functionality that can transfer into nutraceutical products produced with pharmaceutical-style oral-dose processes. Their relevance is strongest where quality consistency and high active loading matter more than purely food-ingredient positioning. [7][8][10]

On the sensory and functional-food side, Kerry’s Tastesense Masking addresses bitterness, astringency and metallic off-notes in protein and functional systems, while Cargill supplies maltodextrin, carrageenan, xanthan gum and lecithin solutions across diluent, coating, controlled-release and processing functions. These competitors operate closer to food and beverage formulation than traditional pharmaceutical excipient suppliers, creating an increasingly overlapping competitive field as nutraceuticals move into consumer-friendly foods and drinks. [3][18]

 

Market Outlook: Value Will Concentrate in Performance, Compliance and Cost-in-Use

The 9.6% market forecast is supported by a structural shift toward higher formulation complexity rather than by a single end-market trend. The strongest value pools are likely to develop around multifunctional direct-compression systems, moisture and delayed-release coatings, taste-masking platforms, clean-label and titanium-dioxide-free reformulation, and stabilizers capable of carrying higher functional-ingredient loads without compromising texture or shelf stability.

For suppliers, the key commercial opportunity is to reduce the customer’s total formulation burden. A higher-priced excipient can still improve cost-in-use if it reduces granulation steps, shortens development time, allows higher active loading, lowers coating time or prevents stability failures. This favors companies that combine materials with application laboratories, regulatory documentation and scale-up support, and it gives technically differentiated regional suppliers room to compete with multinational portfolios.

A material constraint on forecast growth is the time and cost needed to qualify alternative excipients and reformulate finished products. Regulatory differences between food, dietary-supplement and pharmaceutical frameworks can also narrow the addressable use of specific grades across markets. As a result, suppliers with globally consistent specifications, food/nutraceutical suitability documentation and formulation evidence are likely to gain share even when commodity alternatives are available at lower purchase prices.

 

Research Scope and Methodology

Strategic Market Research defines this market by the commercial value of non-active formulation materials used in nutraceutical and dietary-supplement products and in functional food or beverage formats where those materials perform an excipient-like processing, stability, delivery or sensory role. The analysis preserves the supplied 2025 market value, 2032 forecast, segment shares and CAGRs as the quantitative baseline. Displayed segment revenues are calculated from the 2025 market value and published shares to maintain arithmetic consistency. Public-source evidence is used to validate market scope, regulatory developments, consumer demand signals and company product positioning; it is not used to replace the proprietary market-sizing model.

 

Report Coverage Table

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 7.78 Billion
Revenue Forecast in 2032	USD 14.77 Billion
Overall Growth Rate	CAGR of 9.6% (2026 – 2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Million, CAGR (2026 – 2032)
Segmentation	By Excipients Type, By Application, By Geography
By Excipients Type	Binders, Stabilizers, Sweeteners, Coatings and Film Formers
By Application	Dietary Supplements, Functional Foods, Pharmaceuticals, Beverages
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	U.S., Canada, UK, Germany, France, Italy, China, Japan, South Korea, India, Brazil, Mexico, Saudi Arabia, UAE, South Africa
Market Drivers	Rising consumption of dietary supplements and functional foods, growing demand for stable and palatable nutraceutical formulations, increasing use of specialized excipients in tablets, capsules, powders, and fortified beverages, expansion of preventive health and wellness product portfolios
Customization Option	Available upon request